These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 36104870)

  • 1. Milestoning simulation of ligand dissociation from the glycogen synthase kinase 3β.
    Rathnayake S; Narayan B; Elber R; Wong CF
    Proteins; 2023 Feb; 91(2):209-217. PubMed ID: 36104870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mood stabilizing properties of AF3581, a novel potent GSK-3β inhibitor.
    Capurro V; Lanfranco M; Summa M; Porceddu PF; Ciampoli M; Margaroli N; Durando L; Garrone B; Ombrato R; Tongiani S; Reggiani A
    Biomed Pharmacother; 2020 Aug; 128():110249. PubMed ID: 32470749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of binding affinity of 1,2-diphenyline ketone analogues at adenosine triphosphate binding site of glycogen synthase kinase-3β: a molecular docking and dynamic simulation study.
    Dinakar S; Gurubarath M; Dhananjayan K
    J Biomol Struct Dyn; 2023 Jul; 41(11):4847-4862. PubMed ID: 35543239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transient States and Barriers from Molecular Simulations and the Milestoning Theory: Kinetics in Ligand-Protein Recognition and Compound Design.
    Tang Z; Chen SH; Chang CA
    J Chem Theory Comput; 2020 Mar; 16(3):1882-1895. PubMed ID: 32031801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allosteric regulation of glycogen synthase kinase 3β: a theoretical study.
    Buch I; Fishelovitch D; London N; Raveh B; Wolfson HJ; Nussinov R
    Biochemistry; 2010 Dec; 49(51):10890-901. PubMed ID: 21105670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative Prediction of Dissociation Rates of PYK2 Ligands Using Umbrella Sampling and Milestoning.
    Spiriti J; Wong CF
    J Chem Theory Comput; 2024 May; 20(9):4029-4044. PubMed ID: 38640609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of novel scaffold of benzothiazepinones as non-ATP competitive glycogen synthase kinase-3β inhibitors through virtual screening.
    Zhang P; Hu HR; Huang ZH; Lei JY; Chu Y; Ye DY
    Bioorg Med Chem Lett; 2012 Dec; 22(23):7232-6. PubMed ID: 23099099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigating Drug-Target Residence Time in Kinases through Enhanced Sampling Simulations.
    Gobbo D; Piretti V; Di Martino RMC; Tripathi SK; Giabbai B; Storici P; Demitri N; Girotto S; Decherchi S; Cavalli A
    J Chem Theory Comput; 2019 Aug; 15(8):4646-4659. PubMed ID: 31246463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural features underlying selective inhibition of GSK3β by dibromocantharelline: implications for rational drug design.
    Zhang N; Zhong R; Yan H; Jiang Y
    Chem Biol Drug Des; 2011 Mar; 77(3):199-205. PubMed ID: 21244636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simulation of ligand dissociation kinetics from the protein kinase PYK2.
    Spiriti J; Noé F; Wong CF
    J Comput Chem; 2022 Oct; 43(28):1911-1922. PubMed ID: 36073605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identifying Potential Ligand Binding Sites on Glycogen Synthase Kinase 3 Using Atomistic Cosolvent Simulations.
    DasGupta D; Mehrani R; Carlson HA; Sharma S
    ACS Appl Bio Mater; 2024 Feb; 7(2):588-595. PubMed ID: 37141501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and in vitro evaluation of new leads as selective and competitive glycogen synthase kinase-3β inhibitors through ligand and structure based drug design.
    Darshit BS; Balaji B; Rani P; Ramanathan M
    J Mol Graph Model; 2014 Sep; 53():31-47. PubMed ID: 25064440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The structure of phosphorylated GSK-3beta complexed with a peptide, FRATtide, that inhibits beta-catenin phosphorylation.
    Bax B; Carter PS; Lewis C; Guy AR; Bridges A; Tanner R; Pettman G; Mannix C; Culbert AA; Brown MJ; Smith DG; Reith AD
    Structure; 2001 Dec; 9(12):1143-52. PubMed ID: 11738041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetics and free energy of ligand dissociation using weighted ensemble milestoning.
    Ray D; Gokey T; Mobley DL; Andricioaei I
    J Chem Phys; 2020 Oct; 153(15):154117. PubMed ID: 33092382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Docking, molecular dynamics, binding energy-MM-PBSA studies of naphthofuran derivatives to identify potential dual inhibitors against BACE-1 and GSK-3β.
    Kumar A; Srivastava G; Negi AS; Sharma A
    J Biomol Struct Dyn; 2019 Feb; 37(2):275-290. PubMed ID: 29310523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening of potential drug for Alzheimer's disease: a computational study with GSK-3 β inhibition through virtual screening, docking, and molecular dynamics simulation.
    Elangovan ND; Dhanabalan AK; Gunasekaran K; Kandimalla R; Sankarganesh D
    J Biomol Struct Dyn; 2021 Nov; 39(18):7065-7079. PubMed ID: 32779973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual therapeutic approach to modulate Glycogen Synthase kinase -3 beta (GSK-3Β) and inhibitor of nuclear factor kappa kinase-beta (IKK-β) receptors by in silico designing of inhibitors.
    Roy Acharyya S; Sen P; Kandasamy T; Sankar Ghosh S
    J Mol Graph Model; 2022 Sep; 115():108225. PubMed ID: 35636338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, Synthesis and Biological Evaluation of 7-Chloro-9
    Andreev S; Pantsar T; Ansideri F; Kudolo M; Forster M; Schollmeyer D; Laufer SA; Koch P
    Molecules; 2019 Jun; 24(12):. PubMed ID: 31242571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel benzothiazinones (BTOs) as allosteric modulator or substrate competitive inhibitor of glycogen synthase kinase 3β (GSK-3β) with cellular activity of promoting glucose uptake.
    Zhang P; Li S; Gao Y; Lu W; Huang K; Ye D; Li X; Chu Y
    Bioorg Med Chem Lett; 2014 Dec; 24(24):5639-5643. PubMed ID: 25467150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Theoretical Studies on the Selectivity Mechanisms of Glycogen Synthase Kinase 3β (GSK3β) with Pyrazine ATP-competitive Inhibitors by 3DQSAR, Molecular Docking, Molecular Dynamics Simulation and Free Energy Calculations.
    Zhu J; Wu Y; Xu L; Jin J
    Curr Comput Aided Drug Des; 2020; 16(1):17-30. PubMed ID: 31284868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.